In unconjugated hyperbilirubinemia, which of the drug increase the chance for Kernicterus?
**Core Concept**
Unconjugated hyperbilirubinemia is a condition characterized by elevated levels of unconjugated (indirect) bilirubin in the blood. Kernicterus is a potentially life-threatening complication of severe jaundice, occurring when high levels of bilirubin bind to brain cells and cause damage. In this context, certain medications can exacerbate the risk of kernicterus by displacing bilirubin from albumin or increasing bilirubin production.
**Why the Correct Answer is Right**
The correct answer is a drug that can displace bilirubin from albumin, thereby increasing the risk of kernicterus. This is because bilirubin is normally bound to albumin in the blood, which prevents it from crossing the blood-brain barrier and causing damage. However, certain drugs can compete with bilirubin for binding sites on albumin, leading to a decrease in albumin-bound bilirubin and an increase in free (unbound) bilirubin, which is more likely to cause kernicterus.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because sulfonamides do not significantly displace bilirubin from albumin. They may have other adverse effects, but they are not typically associated with an increased risk of kernicterus.
* **Option B:** This option is incorrect because chloramphenicol is not known to displace bilirubin from albumin or increase the risk of kernicterus.
* **Option C:** This option is incorrect because salicylates, such as aspirin, do not significantly displace bilirubin from albumin and are not typically associated with an increased risk of kernicterus.
**Clinical Pearl / High-Yield Fact**
When treating patients with unconjugated hyperbilirubinemia, it is essential to be aware of medications that can increase the risk of kernicterus. This includes sulfonamides, which can displace bilirubin from albumin and exacerbate the condition.
**Correct Answer:** A. Sulfonamides.